NON-ALCOHOLIC FATTY LIVER DISEASE
Clinical trials for NON-ALCOHOLIC FATTY LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new NON-ALCOHOLIC FATTY LIVER DISEASE trials appear
Sign up with your email to follow new studies for NON-ALCOHOLIC FATTY LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diabetes pill trial aims to shrink Kids' fatty livers
Disease control Not yet recruitingThis study is testing if a diabetes medication called empagliflozin can safely reduce fat in the liver of teenagers with obesity-related fatty liver disease (NAFLD). Forty adolescents will take the pill or a placebo daily for six months while also receiving lifestyle counseling. …
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE2 • Sponsor: Justin Ryder • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New fatty liver drug begins first human tests
Disease control Not yet recruitingThis early-stage study aims to test the safety and basic effects of a new drug called XTYW007 in healthy adults and people with high 'bad' cholesterol. Researchers will give single and multiple doses to about 94 participants to see how the body processes the drug and if it affect…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: EARLY_PHASE1 • Sponsor: Xi'an Xintong Pharmaceutical Research Co.,Ltd. • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
AI steps in to catch a silent liver threat missed in ER scans
Diagnosis Not yet recruitingThis study tests a new computer tool designed to catch a common but often overlooked finding on emergency room scans: fatty liver disease. The AI system alerts doctors to the finding, provides a risk assessment for the patient, and suggests appropriate follow-up steps. The goal i…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: NA • Sponsor: Northwestern University • Aim: Diagnosis
Last updated Mar 30, 2026 14:32 UTC
-
Early trial tests if lowering insulin can shrink fatty liver
Knowledge-focused Not yet recruitingThis early-stage study aims to understand if lowering high insulin levels for one week can reduce the liver's production of new fat, a key driver of fatty liver disease. Researchers will compare a drug called diazoxide against a placebo in 25 adults with obesity, insulin resistan…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE1 • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC
-
Scientists test if lowering insulin can fight fatty liver disease
Knowledge-focused Not yet recruitingThis study aims to understand how high insulin levels contribute to fatty liver disease in people who are overweight and insulin resistant. Researchers will temporarily control insulin levels in 36 participants to measure how the liver produces fat and sugar. The goal is to gathe…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE1 • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC